Human Fetal Lung Fibroblast Cells (MRC-5 Line)
The MRC-5 cell line is commonly utilized in vaccine development, as a transfection host in virology research, and for in vitro cytotoxicity testing. Initiated in September 1966 by J. P. Jacobs, the cell line was derived from the human lung tissue of a 14-week-old male fetus aborted from a 27-year-old woman.
Sorry, this page is not
available in your country.
